Page 103 - Book of Abstracts
P. 103

5 International Scientific Online Conference   DOI: https://doi.org/10.15414/2021.9788055224015

            th

               IN VITRO HEMOLYSIS ASSESSMENT OF THYME ESSENTIAL OIL AND ITS PROTECTIVE
                           EFFECT ON OXIDATIVE DAMAGE OF HUMAN ERYTHROCYTES
                                    1
                Maryna Opryshko , Myroslava Maryniuk , Oleksandr Gyrenko , Lyudmyla Buyun ,
                                                                                                        1
                                                                                    1
                                                            1
                                        Halyna Tkachenko , Natalia Kurhaluk
                                                                                 2
                                                            2
                1 M.M. Gryshko National Botanic Garden, National Academy of Science of Ukraine, Kyiv, Ukraine;
                                            E-mail.: maryna.opryshko@meta.ua
                       2 Institute of Biology and Earth Sciences, Pomeranian University in Słupsk, Poland
                  As  the  hemolytic  activity  of  any  compounds  is  considered  as  an  indicator  of  general
             cytotoxicity toward normal healthy cells, the main objective of this study was to evaluate the
             dose-dependent  hemolytic/antihemolytic  potential  of  thymus  essential  oil  (TEO)  using  a
             human erythrocyte model.
                  The venous blood (10–20 ml) was obtained from normal volunteers via venipuncture (7
             females  aged  23–36-years  old).  The  Research  Ethics  Committee  of  the  Regional  Medical
             Commission in Gdańsk (Poland) approved the study (KB-31/18). Human erythrocytes from
             citrated blood were isolated by centrifugation at 3,000 rpm for 10 min and washed two times
             with 4 mM phosphate buffer (pH 7.4) and then re-suspended using the same buffer to the
             desired  hematocrit  level.  The  blood  sample  was  incubated  with  TEO  (Etja,  Elbląg,  Poland),
             respectively (final concentrations were 20 and 10 μg/mL) for 15 min at 25 °C. Samples were
             removed at 20 min of storage for analysis. The untreated erythrocyte samples were used as the
             control  sample.  The  osmotic-induced  hemolysis  of  erythrocytes  was  measured
             spectrophotometrically  with  different  0.1–0.9  %  NaCl  solutions.  The  assay  is  based  on  the
             measuring of the percent of erythrocytes disintegration into hemolytic reagent action (0.1–0.9
             %  NaCl).  The  absorbance  was  read  at  540  nm.  The  disintegration  of  erythrocytes  (%)  at
             different NaCl solutions was expressed as a curve.
                  It was observed that, TEO in final concentration 20 μg/mL caused a significant increase of
             hemolysis in the samples with 0.9–0.5 % NaCl solutions: 13.3 % vs. 4.1 % (0.9 % NaCl), 15.4 %
             vs. 4.3 % (0.8 % NaCl), 16.7 % vs. 5.6 % (0.7 % NaCl), 17.8 % vs. 5.7 % (0.6 % NaCl), and 58 %
             vs. 18.2 % (0.5 % NaCl). The increase of hemolysis was 3.3-fold (0.9 % NaCl), 3.6-fold (0.8 %
             NaCl), 3-fold (0.7 % NaCl), 3.1-fold (0.6 % NaCl), 3.2-fold (0.5 % NaCl), respectively. On the
             contrary,  after  incubation  in  solutions  of  0.4–0.1  %  NaCl,  adding  of  TEO  to  the  human
             erythrocytes  caused  the  decrease  of  hemolysis  (by  14.9  %,  10.5  %,  7.1  %,  and  4.7  %,
             respectively). Treatment of the human erythrocytes by TEA in final concentration 10 μg/mL
             caused  a  statistically  significant  increase  of  hemolysis  in  the  samples  with  0.9–0.6  %  NaCl
             solutions: 5.8 % vs. 1.2 % (0.9 % NaCl), 6.9 % vs. 1.2 % (0.8 % NaCl), 9.3 % vs. 1.5 % (0.7 %
             NaCl), and 13.3 % vs. 2 % (0.6 % NaCl). The increase of hemolysis was 4.8-fold (0.9 % NaCl),
             5.6-fold (0.8 % NaCl),  6.4-fold (0.7 % NaCl),  and 6.8-fold (0.6 % NaCl), respectively. In the
             sample with 0.5–0.1 % NaCl, a difference between the percentage of hemolysis in samples after
             adding  TEO  to  the  erythrocytes  suspension  compared  to  the  untreated  samples  was  non-
             significant (decrease of hemolysis by 2.5 %, 3.3 %, 2.9 %, and 0.1 %). In the sample with 0.5–
             0.1 % NaCl, TEO added to human erythrocyte suspension in final concentration of 10 μg/mL
             exhibited  anti-hemolytic  activity.  Thus,  TEO  screened  in  this  study  possessed  good  anti-
             hemolytic activities using the human erythrocytes model. The interest in the formulation of
             pharmaceuticals, nutraceuticals, and cosmeceuticals based on thymol is due to several studies
             that  have  evaluated  the  potential  therapeutic  uses  of  this  compound  for  the  treatment  of
             disorders  affecting  the  respiratory,  nervous,  and  cardiovascular  systems.  Moreover,  this
             compound also exhibits antimicrobial, antioxidant, anti-carcinogenesis, anti-inflammatory, and
             antispasmodic activities, as well as a potential as a growth enhancer and immunomodulator.

            Keywords: hemolysis, erythrocytes, thymus essential oil, antioxidants.




              th
             5 International Scientific Conference Agrobiodiversity for Improving the Nutrition, Health, Quality of Life and  |102
                                               Spiritual Human Development
                                                                                                          November 3  2021
                                                              rd
   98   99   100   101   102   103   104   105   106   107   108